Piper Sandler Q1 Record Revenues Driven by Debt Capital Markets Surge
PIPR•Piper Sandler recorded its highest quarterly revenues ever in Q1, led by a surge in Debt Capital Markets advisory delivering outsized performance. Healthcare and Medtech advisory fees remained robust even as announced bank M&A deal volume waned and software M&A valuations moderated.
1. Financial Performance
Piper Sandler delivered record Q1 revenues, driven by strong outcomes in Debt Capital Markets advisory, which outperformed other segments and offset slower large bank M&A activity. Equity capital markets market share gains further bolstered overall revenue growth, fueled by significant Healthcare and Medtech transactions.
2. Advisory Segment Insights
Healthcare and Medtech advisory fees remained elevated despite choppy macro conditions, though sequential advisory revenues are expected to decline given reduced sponsor deal launches. The firm cautioned that first-quarter equity capital markets market share is unlikely to be sustainable into Q2.
3. Bank M&A Trends
Announced bank M&A volume decelerated with larger transactions pacing down, while smaller deals continued at a steady clip. Elevated rate volatility heightened derivative desk hedging discussions and transaction completions, reflecting increased client risk management activity.
4. Non-M&A Business Drivers
Non-M&A services excelled in Q1, led by outstanding performance in Debt Capital Markets advisory and solid contributions from restructuring and private capital advisory. Continued momentum in continuation transactions supported ongoing growth in private capital advisory.
